1
|
Strid P, Zapata LB, Tong VT, Zambrano LD, Woodworth KR, Riser AP, Galang RR, Gilboa SM, Ellington SR. Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status-United States, 1 January 2020-25 December 2021. Clin Infect Dis 2022; 75:S317-S325. [PMID: 35717652 PMCID: PMC9214133 DOI: 10.1093/cid/ciac479] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
BACKGROUND Information on the severity of coronavirus disease 2019 (COVID-19) attributable to the Delta variant in the United States among pregnant people is limited. We assessed the risk for severe COVID-19 by pregnancy status in the period of Delta variant predominance compared with the pre-Delta period. METHODS Laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among symptomatic women of reproductive age (WRA) were assessed. We calculated adjusted risk ratios for severe disease including intensive care unit (ICU) admission, receipt of invasive ventilation or extracorporeal membrane oxygenation (ECMO), and death comparing the pre-Delta period (1 January 2020-26 June 2021) and the Delta period (27 June 2021-25 December 2021) for pregnant and nonpregnant WRA. RESULTS Compared with the pre-Delta period, the risk of ICU admission during the Delta period was 41% higher (adjusted risk ratio [aRR], 1.41 [95% confidence interval {CI}, 1.17-1.69]) for pregnant WRA and 9% higher (aRR, 1.09 [95% CI, 1.00-1.18]) for nonpregnant WRA. The risk of invasive ventilation or ECMO was higher for pregnant (aRR, 1.83 [95% CI, 1.26-2.65]) and nonpregnant (aRR, 1.34 [95% CI, 1.17-1.54]) WRA in the Delta period. During the Delta period, the risk of death was 3.33 (95% CI, 2.48-4.46) times the risk in the pre-Delta period among pregnant WRA and 1.62 (95% CI, 1.49-1.77) among nonpregnant WRA. CONCLUSIONS Compared with the pre-Delta period, pregnant and nonpregnant WRA were at increased risk for severe COVID-19 in the Delta period.
Collapse
Affiliation(s)
- Penelope Strid
- Alternate Corresponding Author. Penelope Strid, , 404-718-7986. Centers for Disease Control and Prevention 4770 Buford Highway, Mail stop: S107-2, Atlanta, GA 30341
| | - Lauren B Zapata
- Centers for Disease Control and Prevention, COVID-19 Emergency Response, Epidemiology Task Force, Pregnancy and Infant Linked Outcomes Team, Atlanta, GA, United States
| | - Van T Tong
- Centers for Disease Control and Prevention, COVID-19 Emergency Response, Epidemiology Task Force, Pregnancy and Infant Linked Outcomes Team, Atlanta, GA, United States
| | - Laura D Zambrano
- Centers for Disease Control and Prevention, COVID-19 Emergency Response, Epidemiology Task Force, Pregnancy and Infant Linked Outcomes Team, Atlanta, GA, United States
| | - Kate R Woodworth
- Centers for Disease Control and Prevention, COVID-19 Emergency Response, Epidemiology Task Force, Pregnancy and Infant Linked Outcomes Team, Atlanta, GA, United States
| | - Aspen P Riser
- Centers for Disease Control and Prevention, COVID-19 Emergency Response, Epidemiology Task Force, Pregnancy and Infant Linked Outcomes Team, Atlanta, GA, United States
| | - Romeo R Galang
- Centers for Disease Control and Prevention, COVID-19 Emergency Response, Epidemiology Task Force, Pregnancy and Infant Linked Outcomes Team, Atlanta, GA, United States
| | - Suzanne M Gilboa
- Centers for Disease Control and Prevention, COVID-19 Emergency Response, Epidemiology Task Force, Pregnancy and Infant Linked Outcomes Team, Atlanta, GA, United States
| | - Sascha R Ellington
- Corresponding Author. Sascha Ellington, for the CDC COVID-19 Emergency Response, Pregnancy and Infant Linked Outcomes Team, , 770-488-6037. Centers for Disease Control and Prevention 4770 Buford Highway, Mail stop: S107-2, Atlanta, GA 30341
| |
Collapse
|
2
|
Kasehagen L, Byers P, Taylor K, Kittle T, Roberts C, Collier C, Rust B, Ricaldi JN, Green J, Zapata LB, Beauregard J, Dobbs T. COVID-19-Associated Deaths After SARS-CoV-2 Infection During Pregnancy - Mississippi, March 1, 2020-October 6, 2021. MMWR. MORBIDITY AND MORTALITY WEEKLY REPORT 2021; 70:1646-1648. [PMID: 34818319 PMCID: PMC8612513 DOI: 10.15585/mmwr.mm7047e2] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Pregnant and recently pregnant women are at increased risk for severe illness and death from COVID-19 compared with women who are not pregnant or were not recently pregnant (1,2). CDC recommends COVID-19 vaccination for women who are pregnant, recently pregnant, trying to become pregnant, or might become pregnant in the future.*,† This report describes 15 COVID-19-associated deaths after infection with SARS-CoV-2 (the virus that causes COVID-19) during pregnancy in Mississippi during March 1, 2020-October 6, 2021.
Collapse
|